“…Many drugs were immediately administered as “repurposed drugs”, including both antivirals such as favipiravir, lopinavir/ritonavir, umifenovir, ribavirin, and non-antiviral agents such as azithromycin, enoxaparin, baricitinib, tocilizumab (TCZ) [ 4 , 5 ]. Moreover, nonpharmacological treatments, including the salus per aquam (spa) therapy, whose efficacy is well-demonstrated [ 6 , 7 , 8 , 9 , 10 , 11 , 12 ], have been proposed as a complementary therapy to contrast several alterations associated with the so-called long-COVID syndrome.…”